Many Patients Receive No Benefit From Cholesterol Drugs: Study
A new study finds that cholesterol guidelines have not led to a decrease in cardiovascular deaths, even when they lowered cholesterol levels to target numbers.
Tag Archives: Repatha
-
-
Repatha, Similar Cholesterol Drugs, Overpriced For Benefits They Provide: Study
A new class of cholesterol drugs that includes Repatha and Praluent may be significantly overpriced in the U.S. when you look at the benefits they provide, according to the findings…
-
Praluent, Repatha Costs Outweigh Health Benefits: Study
A new report warns that the cholesterol drugs Praluent and Repatha may be too expensive for the modest benefits they give to patients.
